Emergency use authorization of a new pre-expos... - CLL Support

CLL Support

23,253 members39,949 posts

Emergency use authorization of a new pre-exposure prophylaxis (PrEP) for COVID-19, PEMGARDA™ (VYD222)

bkoffman profile image
bkoffmanCLL CURE Hero
6 Replies

Hi,

Great news for the immunocompromised community including us. Invivyd announced late last week the emergency use authorization of their new pre-exposure prophylaxis (PrEP) for COVID-19, PEMGARDA™ (VYD222).

It’s a one-hour infusion and lasts 3 months and based on titers should be effective against the present VOC of SARS-CoV2. And it was studied in the immunocompromised! It does have a 0.6% risk of anaphylaxis so discuss with your healthcare team but this is great news overall for CLL patients.

Here is the link to the press release: investors.invivyd.com/news-...

Here is the link to the patient fact sheet: invivyd.com/wp-content/uplo...

This makes me happy because as we know for CLL/SLL patients protection from vaccines is incomplete and now we have another prevention option similar to EVUSHELD when it was effective.

CLL Society will be posting more information on our website very soon.

Stay strong.

We are all in this together.

Brian

Brian Koffman MDCM (retired) MS Ed

Co-Founder, Executive VP and Chief Medical Officer

CLL Society, Inc

cllsociety.org

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
6 Replies
elm1 profile image
elm1

thanks for that!!

JigFettler profile image
JigFettlerVolunteer

Thanks Brian! All best wishes to you!

Jig

Peggy4 profile image
Peggy4

That’s good news. Thanks for the info Brian. I presume this is USA only for now?

Here in UK we seem to also be in a measles epidemic!

Peggy

CLLerinOz profile image
CLLerinOzAdministrator

This excellent news is generating great interest, Brian, and those of us outside the US hope that Pemgarda might become available in some other countries before too long, too, although some of us have bad memories of the delays and failure to provide Evusheld in places like Australia and the UK. Here’s hoping, nonetheless.

Have you any information you can share about how ‘Evusheld 2.0’ AZD3152 is progressing?

For those interested, here are some other discussions in our community on the topic of Pemgarda’s recent emergency use authorization (EUA):

healthunlocked.com/cllsuppo...

healthunlocked.com/cllsuppo...

healthunlocked.com/cllsuppo...

CLLerinOz

johnliston profile image
johnliston

Brian, I'm in the Supernova trial. Have you heard anything about the approval of this new Evusheld, and have you heard anything about how these two drugs compare with each other? Is one more effective than the other, does one have fewer side effects? To me a shot of the new Evusheld every six month is a lot better than an infusion every three.

john

Eucalyptus22 profile image
Eucalyptus22

I too am on the Supernova trial and understand that the results are being presented by AZ in Barcelona on 28th April. There is an expectation that Canada and USA are going to go to Emergency Use Authorisation shortly after that. I also understand that here in the UK the MHRA and NICE are currently looking at the data in parallel. Who knows what decision they will make?

Kate

Not what you're looking for?

You may also like...

COVID-19 PrEP A single dose of Regen-Cov® may be effective for pre-exposure prophylaxis (PrEP) without needing

COVID-19 PrEP A single dose of Regen-Cov® (Casirivimab and Imdevimab) may be effective for...
bkoffman profile image
CLL CURE Hero

The FDA has authorized the Emergency use of REGEN-COV for the treatment of COVID-19

For those who don't know; The FDA has authorized the emergency use of REGEN-COV for the treatment...
Tupelomojo profile image

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

Hi, Just back from a frenetic and fantastic ASH, but still have news to share from ASCO. But first...
bkoffman profile image
CLL CURE Hero

A new Study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) (SUPERNOVA)

The aim of this worldwide study is to assess the safety and neutralizing activity of AZD5156 for...
Jm954 profile image
Administrator

ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.

Hi, If you have been on our website recently you have already met Dr. Nabhan talking about patient...
bkoffman profile image
CLL CURE Hero

Moderation team

See all
Newdawn profile image
NewdawnAdministrator
Jm954 profile image
Jm954Administrator
AussieNeil profile image
AussieNeilAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.